On May 13, a standard memorandum of understanding, also known as a MOU, between the FDA and the states was made available for public viewing as part of the regulatory process. The article states that this marks a significant milestone in the agency’s regulation of human drug compounding and reflects years of collaborative dialogue and stakeholder input.
To read more on the article, follow the link below:
FDA Announces Latest Step Toward Finalizing Memorandum of Understanding with States Addressing Compounded Drug Distribution, While Preserving Access
Have questions? Our experts are here to help. Our scientific experts are committed to providing answers to help you in navigating these challenging times.
